1998
DOI: 10.1159/000040855
|View full text |Cite
|
Sign up to set email alerts
|

Double Esterase Staining andOther Neutrophilic Granule Abnormalities in 237 Patients with the Myelodysplastic Syndrome Studied by the Cancer and Leukemia Group B

Abstract: We investigated double (specific and nonspecific) esterase (DE) staining in marrow cells of 237 patients with the myelodysplastic syndromes (MDS). Additional abnormalities of neutrophilic granules were examined cytochemically and immunocytochemically for myeloperoxidase activity and antigen elastase, lactoferrin and CD15 granule-membrane glycoproteins. Abnormal DE staining (≥3% of all nucleated marrow cells) was present in 27% of patients with no difference among different MDS subtypes. However, the prevalence… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
4
0

Year Published

1998
1998
2005
2005

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 8 publications
2
4
0
Order By: Relevance
“…Normal bone marrow contains fewer than 3% of cells expressing a DE‐staining pattern ( Scott et al . 1983 ; Elghetany et al . 1998 ).…”
Section: Discussionsupporting
confidence: 88%
See 2 more Smart Citations
“…Normal bone marrow contains fewer than 3% of cells expressing a DE‐staining pattern ( Scott et al . 1983 ; Elghetany et al . 1998 ).…”
Section: Discussionsupporting
confidence: 88%
“…Alpha‐naphthyl acetate esterase and naphthol ASD chloroacetate esterase were used as substrates as previously described ( Hayhoe & Quaglino 1994). Fewer than 3% of all nucleated marrow cells expressed DE staining, which was consistent with a prior study ( Elghetany et al . 1998 ).…”
Section: Case Reportmentioning
confidence: 99%
See 1 more Smart Citation
“…In addition, MDS may evolve from an existing acquired AA, particularly in patients receiving prolonged treatment with G-CSF [23]. A thorough morphological assessment complemented by cytochemical, immunocytochemical, and cytogenetic studies may provide tools for making such a distinction [9,10,12,26]. Considering the reported extent of apoptotic cells in the BM of MDS patients and the relationship between p53 gene and apoptosis, we evaluated p53 immunostaining to determine whether it can help in the differential diagnosis.…”
Section: Discussionmentioning
confidence: 99%
“…The absence of both ring sideroblasts and increased blasts, as in hypocellular refractory anemia (hypo RA), adds further difficulty [9]. Morphological evidence of bi-or trilineage dysplasia in the peripheral blood (PB) or bone marrow (BM), the presence of clonal cytogenetic abnormalities, and the pattern of CD34 immunostaining of marrow biopsies are evidence for hypo RA [10,12,14,26].…”
Section: Introductionmentioning
confidence: 99%